Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 ,inter alia, to consider and approve unaudited financial results for the ...

Certificate under regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on December 31, 2024.

Brokerage firm Nomura has upgraded shares of Zydus Lifesciences Ltd. to "buy" from its earlier rating of "hold" and also raised its price target to ₹1,140 from ₹1,030 earlier. In a note on Thursday, ...

What are the running costs? The MG4 EV is incredibly good value to buy. Not only is it thousands cheaper than similarly sized rivals, but it has also more standard equipment and is much cheaper on a ...

Shares of Zydus Lifesciences Ltd. are trading with gains of 4.5% on Tuesday, January 7, after the company made two announcements with regards to a drug and an agreement. Earlier on Tuesday, Zydus said ...

Zydus Lifesciences shares gained 5.2 per cent in Tuesday's trade on BSE, logging an intraday high at Rs 1,012 per share. The buying in the stock sparked after the company inked an agreement with CVS ...

Zydus Lifesciences stock trades with 5.17 per cent gain at Rs 1,011 in the afternoon session on the National Stock Exchange (NSE) The stock price of Zydus Lifesciences surged over 5 per cent in ...

Mounjaro starting dosage Dose increase at week 5 Possible additional dose increases Maximum dosage 2.5 mg per week, for 4 weeks After 4 weeks, your doctor will increase your dosage to 5 mg per week.

Ahmedabad: Zydus Lifesciences has informed in a BSE filing that the Company has appointed Vikram Shukla as a President-Parenteral Operations and designated him as the Senior Management Personnel.

Zydus Wellness Ltd share price was up by 1.60% from the previous closing price of ₹1,976.05. Who are peers of Zydus Wellness Ltd? The peers of Zydus Wellness Ltd are Hindustan Unilever Ltd ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...